CTXR logo

Citius Pharmaceuticals, Inc. (CTXR)

Profile

Full Name

Citius Pharmaceuticals, Inc.

Ticker

NASDAQ: CTXR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 2, 2014

Indexes

Not included

Website

https://citiuspharma.com

Employees

23

Key Details

Price

$1.40(+13.82%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$5.97(-8.55% YoY)

PE ratio

-

Next earnings date

Dec 26, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.40
    CTXR price is $1.40

    30-Day Relative Volume

    3.57
    CTXR 30-day relative volume is 3.57

    Price Performance

    Price Today change

    +13.82%
    CTXR price is up +13.82% today

    Price YTD change

    -65%
    CTXR price is down -65% since January 1st

    Price 1-year change

    -90.23%
    CTXR price is down -90.23% year-on-year

    Price 3-year change

    -95.41%
    CTXR price is down -95.41% over the past 3 years

    Price Range

    Price All-time high

    $937.50
    CTXR price is currently -99.85% below its historical high of $937.50

    Price 3-year low

    $0.31
    CTXR price is currently +351.61% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $23.82M
    CTXR market capitalization is $23.82 million

    Market cap 3-year change

    -86.64%
    CTXR market capitalization is down -86.64% over the past 3 years

    Market cap All-time high

    $573.06M
    CTXR market capitalization is currently -95.84% below its historical high of $573.06 million

    Market cap sector rank

    24.81%
    CTXR market capitalization is higher than 24.81% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +135.33%
    CTXR shares outstanding is up +135.33% year-on-year

    Shares Outstanding 3-Year Change

    +191.05%
    CTXR shares outstanding is up +191.05% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.18
    CTXR beta is 1.18

    200-day SMA

    $2.31
    CTXR price is currently -39.28% below its 200-day simple moving average

    50-day SMA

    $1.41
    CTXR price is currently -0.82% below its 50-day simple moving average

    RSI

    42.52
    CTXR 14-day relative strength index is 42.52

    Volume

    3.57
    CTXR 30-day relative volume is 3.57

    ATR

    $0.11
    CTXR average true range is $0.11

    10-day Historical Volatility

    71.32%
    CTXR 10-day historical volatility is 71.32%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    CTXR annual revenue is $0.00

    Revenue Analysts estimate

    -
    CTXR annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    CTXR annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.61%
    CTXR annual revenue is higher than 28.61% of companies in Healthcare sector

    EPS

    EPS

    -$5.97
    CTXR annual earnings per share is -$5.97

    EPS Analysts estimate

    -$2.08
    CTXR annual earnings per share is currently +187.02% higher than the consensus analysts' forecast

    EPS 1-year change

    -8.55%
    CTXR annual earnings per share is down -8.55% year-on-year

    EPS Sector rank

    17.28%
    CTXR annual earnings per share is higher than 17.28% of companies in Healthcare sector

    Profit

    Gross profit

    -$209.60K
    CTXR annual gross profit is -$209.60 thousand

    Gross margin

    -
    CTXR annual gross profit margin value is unknown

    Operating profit

    -$42.00M
    CTXR annual operating income is -$42.00 million

    Operating margin

    -
    CTXR annual operating profit margin value is unknown

    Net income

    -$39.43M
    CTXR annual net profit is -$39.43 million

    Net margin

    -
    CTXR annual net profit margin value is unknown

    Expenses

    Total expenses

    $39.14M
    CTXR annual total expenses is $39.14 million

    Operating expenses

    $41.79M
    CTXR annual total operating expenses is $41.79 million

    Cost of goods sold

    $209.60K
    CTXR annual cost of goods sold is $209.60 thousand

    Selling, general & administrative expenses

    $0.00
    CTXR annual SGA is $0.00

    Depreciation and amortization

    $209.60K
    CTXR annual depreciation & amortization is $209.60 thousand

    Interest expense

    $0.00
    CTXR annual interest expense is $0.00

    Income tax

    $576.00K
    CTXR annual income tax is $576.00 thousand

    EBIT & EBITDA

    EBIT

    -$42.00M
    CTXR annual earnings before interest & taxes is -$42.00 million

    EBITDA

    -$41.79M
    CTXR annual EBITDA is -$41.79 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $116.65M
    CTXR annual total assets is $116.65 million

    Non current assets

    $102.43M
    CTXR annual long term assets is $102.43 million

    Current assets

    $14.22M
    CTXR annual total current assets is $14.22 million

    Cash and cash equivalents

    $3.25M
    CTXR annual cash & cash equivalents is $3.25 million

    Accounts receivable

    -
    CTXR annual accounts receivable value is unknown

    Inventory

    $8.27M
    CTXR annual inventory is $8.27 million

    Liabilities

    Total liabilities

    $42.55M
    CTXR annual total liabilities is $42.55 million

    Long term liabilities

    $6.74M
    CTXR annual total long term liabilities is $6.74 million

    Current liabilities

    $35.81M
    CTXR annual total current liabilities is $35.81 million

    Accounts payable

    $4.93M
    CTXR annual accounts payable is $4.93 million

    Debt

    Total debt

    $262.80K
    CTXR annual total debt is $262.80 thousand

    Total debt 1-year change

    -45.4%
    CTXR annual total debt is down -45.4% year-on-year

    Long term debt

    $21.30K
    CTXR annual long term debt is $21.30 thousand

    Short term debt

    $241.50K
    CTXR annual short term debt is $241.50 thousand

    Equity & Capital

    Shareholders equity

    $70.08M
    CTXR annual stockholders equity is $70.08 million

    Book value

    $70.08M
    CTXR annual book value is $70.08 million

    Retained earnings

    -$201.37M
    CTXR annual retained earnings is -$201.37 million

    Working capital

    -$21.59M
    CTXR annual working capital is -$21.59 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$28.20M
    CTXR annual cash flow from operations is -$28.20 million

    Cash from operations 1-year change

    +2.96%
    CTXR annual cash flow from operations is up +2.96% year-on-year

    Cash from investing

    -$5.00M
    CTXR annual cash flow from investing activities is -$5.00 million

    Cash from investing 1-year change

    -100%
    CTXR annual cash flow from investing activities is down -100% year-on-year

    Cash from financing

    $9.97M
    CTXR annual cash flow from financing activities is $9.97 million

    Cash from financing 1-year change

    -27.89%
    CTXR annual cash flow from financing activities is down -27.89% year-on-year

    CAPEX

    CAPEX

    $5.00M
    CTXR annual capital expenditures is $5.00 million

    CAPEX 1-year change

    +100%
    CTXR annual capital expenditures is up +100% year-on-year

    Free Cash Flow

    Free cash flow

    -$33.20M
    CTXR annual free cash flow is -$33.20 million

    Free cash flow 1-year change

    -14.25%
    CTXR annual free cash flow is down -14.25% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    CTXR annual gross profit margin value is unknown

    Operating margin

    -
    CTXR annual operating profit margin value is unknown

    Net margin

    -
    CTXR annual net profit margin value is unknown

    ROA & ROE

    ROA

    -35.80%
    CTXR annual return on assets is -35.80%

    ROE

    -47.63%
    CTXR annual return on equity is -47.63%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CTXR price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CTXR price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.37
    CTXR price to book ratio is 0.37

    PB ratio Sector rank

    21.75%
    CTXR price to book ratio is higher than 21.75% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    CTXR price to sales ratio value is unknown

    PS ratio Sector rank

    -
    CTXR price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $19.61M
    CTXR enterprise value is $19.61 million

    Enterprise value Sector rank

    28.48%
    CTXR enterprise value is higher than 28.48% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.48
    CTXR EV/EBITDA is -0.48

    EV/EBITDA Sector rank

    53.61%
    CTXR EV/EBITDA is higher than 53.61% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.40
    CTXR annual current ratio is 0.40

    Quick ratio

    0.17
    CTXR annual quick ratio is 0.17

    Leverage

    Debt to equity

    0.00
    CTXR annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    CTXR annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    CTXR piotroski f-score value is unknown

    Altman Z-Score

    -3.49
    CTXR altman z-score is -3.49

    Analyst ratings

    Recent major analysts updates

    Aug 13, 25 D. Boral Capital
    Buy
    Jun 30, 25 D. Boral Capital
    Buy
    Jun 10, 25 D. Boral Capital
    Buy
    Jun 9, 25 D. Boral Capital
    Buy
    May 23, 25 Maxim Group
    Hold
    May 15, 25 D. Boral Capital
    Buy
    Feb 18, 25 D. Boral Capital
    Buy
    Jan 7, 25 D. Boral Capital
    Buy
    Dec 30, 24 D. Boral Capital
    Buy
    Nov 22, 24 D. Boral Capital
    Hold

    Institutional Ownership

    Screeners with CTXR included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Citius Pharmaceuticals, Inc.?
    • Does Citius Pharmaceuticals, Inc. pay dividends?
    • What sector is Citius Pharmaceuticals, Inc. in?
    • What industry is Citius Pharmaceuticals, Inc. in?
    • What country is Citius Pharmaceuticals, Inc. based in?
    • When did Citius Pharmaceuticals, Inc. go public?
    • Is Citius Pharmaceuticals, Inc. in the S&P 500?
    • Is Citius Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Citius Pharmaceuticals, Inc. in the Dow Jones?
    • When was Citius Pharmaceuticals, Inc.'s last earnings report?
    • When does Citius Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Citius Pharmaceuticals, Inc.?

    The ticker symbol for Citius Pharmaceuticals, Inc. is NASDAQ:CTXR

    Does Citius Pharmaceuticals, Inc. pay dividends?

    No, Citius Pharmaceuticals, Inc. does not pay dividends

    What sector is Citius Pharmaceuticals, Inc. in?

    Citius Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Citius Pharmaceuticals, Inc. in?

    Citius Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Citius Pharmaceuticals, Inc. based in?

    Citius Pharmaceuticals, Inc. is headquartered in United States

    When did Citius Pharmaceuticals, Inc. go public?

    Citius Pharmaceuticals, Inc.'s initial public offering (IPO) was on October 2, 2014

    Is Citius Pharmaceuticals, Inc. in the S&P 500?

    No, Citius Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Citius Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Citius Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Citius Pharmaceuticals, Inc. in the Dow Jones?

    No, Citius Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Citius Pharmaceuticals, Inc.'s last earnings report?

    Citius Pharmaceuticals, Inc.'s most recent earnings report was on August 12, 2025

    When does Citius Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Citius Pharmaceuticals, Inc. is December 26, 2025
    On this page